Literature DB >> 23563400

Mouse platforms jostle for slice of humanized antibody market.

Nuala Moran.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563400     DOI: 10.1038/nbt0413-267

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  The biosimilar price is right.

Authors:  David Gaugh
Journal:  Nat Biotechnol       Date:  2013-11       Impact factor: 54.908

2.  New models of human immunity.

Authors:  Hergen Spits
Journal:  Nat Biotechnol       Date:  2014-04       Impact factor: 54.908

Review 3.  Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.

Authors:  Jing Liu; Bin Yang; Jun Ke; Wenjia Li; Wen-Chen Suen
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

4.  Back to the future: recombinant polyclonal antibody therapeutics.

Authors:  Xian-Zhe Wang; Vincent W Coljee; Jennifer A Maynard
Journal:  Curr Opin Chem Eng       Date:  2013-11       Impact factor: 5.163

5.  Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies.

Authors:  Weihsu C Chen; Christopher M Murawsky
Journal:  Front Immunol       Date:  2018-03-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.